DelveInsight’s “Hypoxia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the Hypoxia, historical and forecasted epidemiology as well as the Hypoxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Hypoxia market report provides current treatment practices, emerging drugs, Hypoxia market share of the individual therapies, and current and forecasted Hypoxia market Size from 2019 to 2032 segmented by seven major markets. The report also covers current Hypoxia treatment practice/algorithm, and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Some of the key facts of the Hypoxia Market Report
Hypoxia is a common disorder. However, the causes of hypoxia are multiple, and its incidence is variable. Some of these causes are very common like pneumonia or chronic obstructive pulmonary disease (COPD); others are quite rare like hypoxia due to reduced oxygen tension at high altitudes or due to cyanide poisoning.
As per the study conducted by Myriam Lacerte et al. (2020), The incidence rates of Hypoxic Brain Injury are approximately 50 per 100,000 population, and survival-to-discharge rates of roughly 8% which represents over 10,000 patients per year in the United States alone.
As per the study conducted by Phillip Ferdinand et al. (2016), Sulter et al. reported that 63% of stroke patients had at least one episode of hypoxia, defined as a saturation of less than 96% for more than 5 minutes.
Got queries? Click here to know more about Hypoxia Market Landscape
Hypoxia is a state in which oxygen is not available in sufficient amounts at the tissue level to maintain adequate homeostasis; this can result from inadequate oxygen delivery to the tissues either due to low blood supply or low oxygen content in the blood.
Hypoxia can be distinguished into four types, the hypoxemic type, in which the oxygen pressure in the blood going to the tissues is too low to saturate the hemoglobin; the anemic type, in which the amount of functional hemoglobin is too small, and hence the capacity of the blood to carry oxygen is too low; the stagnant type, in which the blood is or may be normal but the flow of blood to the tissues is reduced or unevenly distributed; and the histotoxic type, in which the tissue cells are poisoned and are therefore unable to make proper use of oxygen. In its extreme form, where oxygen is entirely absent, the condition is called anoxia. Classic causes of hypoxia include hypoventilation, ventilation-perfusion mismatch, low oxygen content in the air, right-to-left shunting, or impaired diffusion. Leaving hypoxia untreated for prolonged periods leads to permanent organ injury including death.
Hypoxia Epidemiology Insights
As per Biogen 2022, it is estimated that nearly two million people in the United States and the European Union will have a stroke each year.
According to Miao-Kun Sun, brain hypoxia-ischemia, often resulting in a stroke, is a common disorder with a high rate of morbidity and mortality from newborns to the elderly.
As per the National Center for Chronic Disease Prevention and Health Promotion
Stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States.
Every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes.
About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.
Hypoxia Epidemiology Segmentation
Hypoxia total incident cases.
Hypoxia treatable cases.
And many others.
Hypoxia Market Outlook
The market comprises a variety of options for the treatment of Hypoxia. Treatment of vascular brain disorders has a great impact clinically, financially, and socially throughout the world. Prevention of their occurrence through lifestyle adjustments and clinical antihypertensive treatment is an essential part of the therapy to reduce stroke probability and vascular malfunction-related gradual decline in memory. Treatment depends on the underlying cause of the hypoxia, the most important treatment for cerebral hypoxia involves removing the source of the oxygen deprivation, along with extensive physical, occupational, or speech therapy to teach the brain how to work around any damaged areas. Such therapy can be challenging and emotionally draining, but the more committed treatment approaches.
Management of hypoxia falls under 3 categories: maintaining patent airways, increasing the oxygen content of the inspired air, and improving the diffusion capacity.Some other treatments include drugs to prevent future hypoxia episodes; this may include the use of blood thinners, antibiotics to treat infections that caused or resulted from the hypoxia, surgery to remove any blockages or to discover the source of the blockage. Also, it is supported by the use of assistive gear, such as a wheelchair, psychotherapy and basic life-support systems (mechanical ventilation to secure the airway; fluids, blood products, or medications to support blood pressure and heart rate; and medications to suppress seizures).
Learn more by requesting for sample @ Hypoxia Market Trends
Hypoxia Key Companies
And many others.
TMS – 007
And many others.
Table of Contents
Executive Summary of Hypoxia
Disease Background and Overview
Epidemiology and patient population
Hypoxia Emerging Therapies
Hypoxia Market Outlook
Market Access and Reimbursement of Therapies
Hypoxia Report Methodology
Click here to read more about Hypoxia Market
Hypoxia – Epidemiology Forecast to 2032
DelveInsight’s “Hypoxia – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Hypoxia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States